Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T. Hahn, Matthew Lawlor, Charles J. Davidson, Vinay Badhwar, Anna Sannino, Ernest Spitzer, Philipp Lurz, Brian R. Lindman, Yan Topilsky, Suzanne J. Baron, Scott Chadderdon, Omar Khalique, Gilbert H.L. Tang, Maurizio Taramasso, Paul Grayburn, Luigi P. Badano, Jonathon Leipsic, JoAnn Lindenfeld, Stephan Windecker, Sreekanth Vemulapalli, Björn Redfors, Maria Alu, David J. Cohen, Josep Rodés‐Cabau, Gorav Ailawadi, Michael J. Mack, Ori Ben‐Yehuda, Martin B. Leon, Jörg Hausleiter, Suzanne V. Arnold, Vinayak Bapat, Natalia Berry, Philipp Blanke, Daniel Burkhoff, Megan Coylewright, Neal Duggal, Benjamin Z. Galper, Isaac George, Mayra Guerrero, Nadira Hamid, Vikrant Jagadeesan, Susheel Kodali, Mitch Krucoff, Roberto M. Lang, Mahesh V. Madhavan, Vallerie McLaughin, Roxana Mehran, François Philippon, Sanjum S. Sethi, Matheus Simonato, Robert L. Smith, Nishtha Sodhi, John A. Spertus, Thomas J. Stocker, Gregg W. Stone
Abstract
Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options. Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options. The Supplemental Material can be viewed in the online version of this article [https://dx.doi.org/10.1016/j.athoracsur.2023.09.018] on https://www.annalsthoracicsurgery.org. The Supplemental Material can be viewed in the online version of this article [https://dx.doi.org/10.1016/j.athoracsur.2023.09.018] on https://www.annalsthoracicsurgery.org. Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown significantly over the last 10 years given the natural history studies showing a high disease prevalence1Topilsky Y. Maltais S. Medina Inojosa J. et al.Burden of tricuspid regurgitation in patients diagnosed in the community setting.J Am Coll Cardiol Img. 2019; 12: 433-442Crossref Scopus (357) Google Scholar, 2Tung M. Nah G. Tang J. Marcus G. Delling F.N. Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.Open Heart. 2022; 9e002039https://doi.org/10.1136/openhrt-2022-002039Crossref PubMed Scopus (3) Google Scholar, 3Offen S. Playford D. Strange G. Stewart S. Celermajer D.S. Adverse prognostic impact of even mild or moderate tricuspid regurgitation: insights from the National Echocardiography Database of Australia.J Am Soc Echocardiogr. 2022; 35: 810-817Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar and poor outcomes associated with increasing TR severity, even after adjusting for comorbidities.3Offen S. Playford D. Strange G. Stewart S. Celermajer D.S. Adverse prognostic impact of even mild or moderate tricuspid regurgitation: insights from the National Echocardiography Database of Australia.J Am Soc Echocardiogr. 2022; 35: 810-817Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar, 4Chorin E. Rozenbaum Z. Topilsky Y. et al.Tricuspid regurgitation and long-term clinical outcomes.Eur Heart J Cardiovasc Imaging. 2020; 21: 157-165PubMed Google Scholar, 5Wang N. Fulcher J. Abeysuriya N. et al.Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.Eur Heart J. 2019; 40: 476-484Crossref PubMed Scopus (163) Google Scholar However, a number of gaps in our understanding of the disease as well as the rapid expansion of transcatheter solutions for structural heart disease have increased the need for further research and trials. Indications for isolated tricuspid valve (TV) surgery have poor penetration into clinical practice, which may be related to reported high in-hospital mortality rates, partly associated with late clinical diagnosis.6Scotti A. Sturla M. Granada J.F. et al.Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies.EuroIntervention. 2022; 18: 840-851Crossref PubMed Scopus (12) Google Scholar Transcatheter alternatives to surgical intervention are being investigated; yet, appropriate patient selection, goals of therapy, and clinically meaningful outcomes are unknown. Considering these challenges, standardized clinical trial pathways and endpoint definitions to evaluate treatment outcomes in TR patients are needed. The Heart Valve Collaboratory is a multidisciplinary community of physicians, regulators, industry partners, and patient advocates who organized a comprehensive meeting to define the knowledge gaps in our understanding of TR, standardize definitions and methods to assess disease severity, and develop feasible and efficient trial designs. This first Tricuspid Valve Academic Research Consortium (TVARC) document describes the current understanding of the disease state, natural history, and treatment options. The paper includes a proposal for general categories of clinical trial endpoints. A second planned TVARC document will focus on further defining trial endpoints and discusses trial design options. Importantly, TVARC is not a guideline intended to influence clinical practice, but is a document intended to inform clinical research and, in particular, clinical trials. Unlike a guideline, which must rely on evidence-based medicine for recommendations, this document aims to standardize trial endpoints to address gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency across trials and may strengthen the evidence required for guideline recommendations. Given the dynamic field of TR therapeutics, our understanding of its disease state will likely increase with time, and as treatment options expand, trial design and endpoints will undoubtedly evolve. This document is, therefore, intended to be a “living document,” which will allow periodic updating as our knowledge expands. In the current literature, various abbreviations are used for the description of transcatheter valve procedures. Table 1 shows standardized common abbreviations within this academic research consortium.Table 1Suggested Standardized Abbreviations in the Context of Tricuspid Valve InterventionsAbbreviationFull NameDescriptionTTVITranscatheter tricuspid valve interventionTo be used for any tricuspid valve repair or replacement techniqueTTVRTranscatheter tricuspid valve replacementTo be used for any tricuspid valve replacement, including orthotopic and heterotopic techniquesT-TEERTricuspid valve transcatheter edge-to-edge repairTo be used for tricuspid leaflet-based edge-to-edge repair techniquesTTV RepairTranscatheter tricuspid valve repairTo be used for any tricuspid valve repair techniqueA-STRAtrial secondary tricuspid regurgitantTo be used to indicate secondary tricuspid regurgitation with atrial/annular dilatation as the main mechanism of regurgitationV-STRVentricular secondary tricuspid regurgitationTo be used to indicate secondary tricuspid regurgitation with ventricular dilatation/dysfunction as the main mechanism of regurgitationPTRPrimary tricuspid regurgitationTo be used to indicate tricuspid regurgitation caused by leaflet abnormalitiesLTR-ALead-associated tricuspid regurgitation, type ATo be used to indicate tricuspid regurgitation caused by cardiac implantable electronic device caused regurgitationLTR-BLead-associated tricuspid regurgitation, type BTo be used to indicate tricuspid regurgitation not related directly to cardiac implantable electronic device Open table in a new tab Historically, TR is viewed as a binary classification, which includes primary TR, where leaflet abnormalities are the cause of regurgitation, and secondary diseases, where leaflets are normal but structural changes of the annulus or right ventricle (RV) result in insufficient leaflet coaptation. Currently, a more comprehensive classification system for TR etiologies more appropriately encompasses the pathophysiology of this multifaceted disease (Table 2, Figure 1).7Praz F. Muraru D. Kreidel F. et al.Transcatheter treatment for tricuspid valve disease.EuroIntervention. 2021; 17: 791-808Crossref PubMed Scopus (91) Google Scholar,8Lancellotti J. et of regurgitation: and of Valvular Heart Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google Scholar TR etiologies may be associated with M. Topilsky Y. of tricuspid regurgitation: and prognostic Am Coll Cardiol Img. 2019; 12: Scopus Google Scholar, et in etiology and in patients with tricuspid J 2021; Full Text Full Text PDF PubMed Scopus Google Scholar, M. F. et secondary tricuspid regurgitation is associated to more the ventricular Cardiovasc 2022; Scopus Google Scholar, F. et tricuspid regurgitation: and impact on Cardiovasc 2022; PubMed Scopus Google Scholar a of current classification The main changes to the TR classification the secondary TR into secondary tricuspid regurgitation and ventricular secondary tricuspid regurgitation a for TR associated with cardiac implantable electronic device as tricuspid regurgitation and into type A is the TR, and type is (Table 2, Figure mechanism of secondary TR may be by changes that as a result of the changes associated with a disease of TR by and TR of or leaflet normal of leaflet leaflet or or leaflet normal or TR may result in with leaflet of secondary ventricular dilatation leaflet or heart or or dilatation and secondary TR may result in with leaflet dilatation related to dilatation/dysfunction dilatation leaflet TR leaflet or may be and not the mechanism of tricuspid regurgitation, may impact transcatheter device tricuspid valve on primary disease or implantable electronic pulmonary heart with heart with tricuspid regurgitation, type tricuspid regurgitation, type pulmonary pulmonary right heart right tricuspid TR, tricuspid TR may result in with leaflet may be and not the mechanism of tricuspid regurgitation, may impact transcatheter device Open table in a new tab implantable electronic pulmonary heart with heart with tricuspid regurgitation, type tricuspid regurgitation, type pulmonary pulmonary right heart right tricuspid TR, tricuspid Given the that patients with have outcomes with M. F. et secondary tricuspid regurgitation is associated to more the ventricular Cardiovasc 2022; Scopus Google F. et tricuspid regurgitation: and impact on Cardiovasc 2022; PubMed Scopus Google Scholar defining this for trials may be Table and for defining on current F. et tricuspid regurgitation: and impact on Cardiovasc 2022; PubMed Scopus Google et guideline for the management of patients with heart a of the of Heart on Am Coll 2021; PubMed Scopus Google Scholar understanding the from a of et right ventricular and by and of the of of Am Soc Echocardiogr. 2021; Full Text Full Text PDF PubMed Scopus Google et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google and is a and the primary disease will the of that define of pulmonary will on the patient has or pulmonary patients with primary and may have normal The main and of of leaflet dilatation of the right in the of normal and as well as normal and of pulmonary is likely will be a of patients who have of and of and be research may a is a of patients with and to and Tricuspid is a of the Tricuspid Valve Academic Research Consortium (TVARC) and the Tricuspid primary TR or primary TR or the of within the or should be used to define of leaflet in the of a right and normal and and leaflet with within the and the may be for research studies and heart the of within the or should be used to define of leaflet in the of a right and normal and and leaflet with within the and the may be for research studies and and to and ventricular the of within the or should be used to define of leaflet in the of a right and normal and and leaflet with within the and the may be for research studies and be given the etiologies of or pulmonary and primary pulmonary the of within the or should be used to define of leaflet in the of a right and normal and and leaflet with within the and the may be for research studies be given the etiologies of or pulmonary and primary be given the etiologies of or pulmonary and primary be given the etiologies of or pulmonary and primary secondary tricuspid implantable electronic ventricular pulmonary pulmonary pulmonary right right right ventricular right ventricular tricuspid TR, tricuspid ventricular secondary tricuspid This is a of the Tricuspid Valve Academic Research Consortium (TVARC) and the Tricuspid primary TR or In the of within the or should be used to define of leaflet in the of a right and normal and and leaflet with within the and the may be for research studies and F. et tricuspid regurgitation: and impact on Cardiovasc 2022; PubMed Scopus Google and Muraru D. et heart and in patients with the and the ventricular of tricuspid Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google be given the etiologies of or pulmonary and primary Open table in a new tab secondary tricuspid implantable electronic ventricular pulmonary pulmonary pulmonary right right right ventricular right ventricular tricuspid TR, tricuspid ventricular secondary tricuspid Echocardiography is the used to assess TR severity, and The of Echocardiography a and to TR which in a moderate and D. et for of regurgitation: a from the of Echocardiography in with the for Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar that to be used The increasing mortality associated with increasing TR F. et of a to secondary tricuspid Am Coll Cardiol Img. 2021; Scopus Google Y. et of impact on and for and tricuspid regurgitation Heart J Cardiovasc Imaging. 2020; 21: PubMed Scopus Google Scholar The need for a new tricuspid regurgitation Heart J Cardiovasc Imaging. 18: PubMed Scopus Google Scholar G. M. et al.Transcatheter edge-to-edge repair for of tricuspid regurgitation: outcomes of the 2019; Full Text Full Text PDF PubMed Scopus Google Scholar, G. M. et al.Tricuspid valve repair with the outcomes of the 2021; PubMed Scopus Google Scholar, S. et of the transcatheter valve repair system for tricuspid Am Coll 2021; PubMed Scopus Google et of a transcatheter tricuspid valve trial Am Coll PubMed Scopus Google Scholar and a trial of transcatheter device N. et al.Transcatheter repair for patients with tricuspid J PubMed Scopus Google Scholar to the or of the of TR to and The of the TR the N. et al.Transcatheter repair for patients with tricuspid J PubMed Scopus Google Scholar The of and of state that the further of patients for transcatheter with disease into and may have prognostic J. et of regurgitation: and of Valvular Heart Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google A. F. F. et for the management of heart Heart J. 2022; PubMed Scopus Google Scholar TVARC the of the in this that the for patients into transcatheter device trials to TR endpoint Table shows and with for the TR and for TR Tricuspid or or or in and or may have heart or mild a between and that studies of should define the is for right and and and and Tricuspid methods TR, tricuspid a between and that studies of should define the is for right and D. et for of regurgitation: a from the of Echocardiography in with the for Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google and J. et of regurgitation: and of Valvular Heart Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google and and The need for a new tricuspid regurgitation Heart J Cardiovasc Imaging. 18: PubMed Scopus Google Scholar Open table in a new tab TR, tricuspid TR J. et of regurgitation: and of Valvular Heart Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google Scholar The is used and is associated with E. Rozenbaum Z. Topilsky Y. et al.Tricuspid regurgitation and long-term clinical outcomes.Eur Heart J Cardiovasc Imaging. 2020; 21: 157-165PubMed Google F. et of a to secondary tricuspid Am Coll Cardiol Img. 2021; Scopus Google G. et regurgitation and in heart with Am Coll Cardiol Img. 2021; Scopus Google Scholar of this are to result in of the A. G. N. E. J. tricuspid regurgitation a of and Am Coll Cardiol Img. 2019; 12: Scopus Google Scholar, Y. et of tricuspid regurgitation and a Am Soc Echocardiogr. 2019; Full Text Full Text PDF PubMed Scopus Google Scholar, M. G. of for the of tricuspid valve and regurgitation: a 2020; PubMed Scopus Google Scholar The new TR which may be used for clinical the of by the with of This may be by for the of the valve leaflet and the of the tricuspid M. et of the on the of tricuspid regurgitation Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google Scholar In studies of methods for and have with A. G. N. E. J. tricuspid regurgitation a of and Am Coll Cardiol Img. 2019; 12: Scopus Google F. et between and for comprehensive tricuspid annulus and valve in tricuspid regurgitation: for tricuspid regurgitation and transcatheter Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar but further The current methods of TR, as well as a by are in Figure of methods the and by well with cardiac J. et of regurgitation: and of Valvular Heart Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google A. F. F. et for the management of heart Heart J. 2022; PubMed Scopus Google Y. A. J. of of tricuspid regurgitation Am Coll Cardiol Img. 2020; Scopus Google Scholar of and of the of the D. et for of regurgitation: a from the of Echocardiography in with the for Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar by of TR Y. D. et history of tricuspid regurgitation by Am Coll 2020; PubMed Scopus Google Scholar further are to from D. et of the tricuspid valve and right heart Am Coll Cardiol Img. 2019; 12: Scopus Google Scholar and may evidence of TR to the dynamic of TR should be in is The on as well as the to should be TR by any TR should be patients are on therapy, with pulmonary and normal The of of TR is the of which may the of Y. M. et management, and outcomes of patients with multiple heart a of the Research Valvular Heart Heart J. 2022; PubMed Scopus Google F. D. E. et is not pathophysiology, and management in and Cardiovasc 2021; Google Scholar TR is more common with and is associated with poor A. J. et al.Tricuspid regurgitation is associated with increased of mortality in patients with and of the or Am Coll Cardiol Scopus Google Scholar may cause of the of regurgitation and A. S. et clinical and Am Heart 2019; Scopus Google Scholar device of TR, may be of A. F. et and outcomes of transcatheter tricuspid valve interventions: a systematic review and Cardiovasc 2022; Scopus Google Scholar which may the of the tricuspid annulus is the tricuspid is likely to after surgical or transcatheter or tricuspid transcatheter edge-to-edge repair and have not been associated with outcomes M. D. et impact of tricuspid valve after transcatheter edge-to-edge tricuspid valve 2019; PubMed Scopus Google Scholar In can after transcatheter valve replacement, of leaflet structural valve or The that should be are of and and and the for by of and are of are reported for surgical as well as transcatheter and are in Supplemental Table right heart associated with TR can be by the which may to and and cardiac in and and or ventricular TR is associated with and of in cardiac including and F. ventricular in pathophysiology, clinical and management of right ventricular PubMed Scopus Google Scholar The of TR and right heart disease and disease Table and, TR for multiple studies that increasing of TR is associated with progressively worse outcomes of pulmonary and ventricular N. Fulcher J. Abeysuriya N. et al.Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.Eur Heart J. 2019; 40: 476-484Crossref PubMed Scopus (163) Google Scholar A that even mild TR is associated with worse outcomes with S. Playford D. Strange G. Stewart S. Celermajer D.S. Adverse prognostic impact of even mild or moderate tricuspid regurgitation: insights from the National Echocardiography Database of Australia.J Am Soc Echocardiogr. 2022; 35: 810-817Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar However, of and that TR may be a for cardiac or comorbidities. studies have to TR from and to assess outcomes for etiologies primary TR associated with A. E. et tricuspid regurgitation is a for in patients percutaneous Am Coll PubMed Scopus Google Scholar and D. J. et tricuspid regurgitation is associated with poor long-term PubMed Scopus Google Scholar is associated with even for is associated with mortality in Y. et of isolated tricuspid Am Coll Cardiol Img. Scopus Google N. S. et of isolated tricuspid regurgitation in patients with ventricular and pulmonary Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar studies that outcomes are worse for patients with M. F. et secondary tricuspid regurgitation is associated to more the ventricular Cardiovasc 2022; Scopus Google F. et tricuspid regurgitation: and impact on Cardiovasc 2022; PubMed Scopus Google Scholar a for intervention the of heart surgery TR or dilatation is et guideline for the management of patients with heart a of the of Heart on Am Coll 2021; PubMed Scopus Google A. F. F. et for the management of heart Heart J. 2022; PubMed Scopus Google Scholar A trial this showing that the of valve repair of moderate TR but not mild TR with dilatation is associated with in TR et tricuspid repair in patients with J 2022; PubMed Scopus Google Scholar TR right heart leading to dilatation of the tricuspid D. et is a of tricuspid annulus in tricuspid regurgitation: a Heart J Cardiovasc Imaging. 2021; PubMed Scopus Google Scholar and S. et al.Tricuspid regurgitation and the right ventricle in and of 2019; PubMed Scopus Google Scholar The and in the right heart further TR and to a by and clinical Y. et of isolated tricuspid Am Coll Cardiol Img. Scopus Google Scholar The of and is in the etiologies of is associated with with which is associated with and Muraru D. et heart and in patients with the and the ventricular of tricuspid Heart J Cardiovasc Imaging. 2022; PubMed Scopus Google Scholar and are by and of from current are in Table the of of Echocardiography has for and on and which may be in clinical et right ventricular and by and of the of of Am Soc Echocardiogr. 2021; Full Text Full Text PDF PubMed Scopus Google et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar of the of tricuspid which the of the which for of of can outcomes in patients with D. Y. et and prognostic of to right ventricular Heart J Cardiovasc Imaging. 2020; 21: PubMed Scopus Google Scholar and may be to in patients transcatheter tricuspid valve intervention M. S. D. et ventricular in transcatheter edge-to-edge tricuspid valve Am Coll Cardiol Img. 2021; Scopus Google Scholar and may be in patients with M. G. E. et tricuspid regurgitation: a and prognostic of in J 2022; Full Text Full Text PDF PubMed Scopus Google Scholar current not define of in a proposal for to be used in clinical trials is in Table and is on normal et for cardiac by in from the of Echocardiography and the of Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar of et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar as well as outcomes D. M. et of for to tricuspid regurgitation by Heart J Cardiovasc Imaging. 2021; PubMed Scopus Google Scholar and will given the of these of of and with from and et right ventricular and by and of the of of Am Soc Echocardiogr. 2021; Full Text Full Text PDF PubMed Scopus Google Scholar and and et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google right ventricular of right right ventricular tricuspid Open table in a new tab Table of of Tricuspid Tricuspid annulus with from and et for cardiac by in from the of Echocardiography and the of Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar and et right ventricular and by and of the of of Am Soc Echocardiogr. 2021; Full Text Full Text PDF PubMed Scopus Google Scholar and and et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google to to right right ventricular Open table in a new tab Table for for et ventricular in tricuspid regurgitation: prognostic of Heart J Cardiovasc Imaging. et ventricular in tricuspid regurgitation: prognostic of Heart J Cardiovasc Imaging. et of right ventricular to heart and the Am J right right ventricular tricuspid et ventricular in tricuspid regurgitation: prognostic of Heart J Cardiovasc Imaging. et of right ventricular to heart and the Am J Open table in a new tab with from and et right ventricular and by and of the of of Am Soc Echocardiogr. 2021; Full Text Full Text PDF PubMed Scopus Google Scholar and and et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar right ventricular of right right ventricular tricuspid with from and et for cardiac by in from the of Echocardiography and the of Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar and et right ventricular and by and of the of of Am Soc Echocardiogr. 2021; Full Text Full Text PDF PubMed Scopus Google Scholar and and et of right ventricular and of the of Echocardiography Am Soc Echocardiogr. Full Text Full Text PDF PubMed Scopus Google Scholar to to right right ventricular right right ventricular tricuspid a more of cardiac and of the right and right are for the appropriate and of transcatheter the for as well as structural and may have in patients with TR. of the right heart is in Supplemental Table of pressures is for understanding TR pulmonary in patients with TR has been associated with worse outcomes M. et mortality after transcatheter tricuspid valve repair in heart Am Coll Cardiol 2021; Scopus Google Scholar Echocardiography of well with in patients with TR, but may is rapid of and which may with TR with or a of pressures with right heart M. G. et for the and treatment of pulmonary Heart J. Scopus Google Scholar The of pulmonary in patients with TR is even more given the that may in patients with A that high pressures by with pressures by is associated with poor outcomes M. et and of pulmonary in tricuspid regurgitation and for transcatheter tricuspid valve Heart J. 2020; PubMed Scopus Google Scholar that should be by right heart are in Supplemental Table The pulmonary as the of to has as a of and worse in patients with moderate or TR pulmonary et in patients with tricuspid valve regurgitation: a for Heart J Cardiovasc Imaging. PubMed Scopus Google Scholar of the of the to of ventricular to may further to describes a state where is to the pulmonary the can cardiac A. F. et heart to pulmonary and Am Coll PubMed Scopus Google Scholar of have been to of pulmonary has been the In to et ventricular in patients transcatheter tricuspid valve repair for tricuspid Am Coll Cardiol 2021; Scopus Google Scholar or N. M. M. et of right ventricular and pulmonary in transcatheter tricuspid repair Am Coll Cardiol 2020; Scopus Google Scholar is associated with outcomes patients transcatheter M. et and of pulmonary in tricuspid regurgitation and for transcatheter tricuspid valve Heart J. 2020; PubMed Scopus Google J. et and in patients transcatheter tricuspid valve Am Coll 2022; PubMed Scopus Google Scholar the of in patients with TR, these studies that by may The of in may have